TRCT
LRND icon

Tower Research Capital (TRC)’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

Tower Research Capital (TRC)’s Portfolio LRND Stock Details LRND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$28 – 6032
2023
Q4 		$28 Hold
1
– – ﹤0.01% 5800
2023
Q3 		$25 Hold
1
– – ﹤0.01% 5824
2023
Q2 		$26 Buy
+1
New +$24 ﹤0.01% 5912

Other funds holding LRND

NYLIM
New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return
CCP
Clarity Capital Partners Newport Beach, California $280M AUM 25.04% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Tower Research Capital (TRC)'s LRND Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) in Q1 2024, closing a stake of 1 share — an estimated $28 sold.

Tower Research Capital (TRC) first reported a position in LRND in Q2 2023 and held it in 3 quarters. The position peaked at $28 in Q4 2023. 3 funds tracked by Wall St. Rank hold LRND as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF share in Q1 2024, an estimated $28.
  • Tower Research Capital (TRC) first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q2 2023 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position peaked at $28 in Q4 2023.
  • 3 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.